Customs officers must now manually check import documents for healthcare products. This manual verification applies even to facilitated imp...

Karnataka's industries minister will lead a delegation to France and the Netherlands. This high-level team aims to attract global companies...

Lord's Mark Industries Limited is making a strategic move into the Caribbean by forming a partnership that will set up pathology laboratori...

In a strategic shift, Lord's Mark Industries is set to launch an extensive healthcare expansion alongside a business demerger. This initiat...

Lord's Mark Industries has obtained a license for its groundbreaking Biomescan Analytics Platform, which specializes in assessing the gut m...

To bolster India's medical device industry, a strategic pivot toward international markets and enhanced global presence is essential. Foste...

Global private equity firms are expanding beyond hospitals into India's broader healthcare ecosystem, with Warburg Pincus, TA Associates, B...

Several global private equity firms are exploring a significant stake purchase in Agappe Diagnostics. This potential deal involves both exi...

India's Drugs Technical Advisory Board decides against waiving clinical trials for In-vitro Diagnostics despite their approval in other cou...

"Applied Biosystems CoviPath COVID-19 RT-PCR Kit has been approved under MDR 2017 rules for in vitro diagnostic use by the Indian Council f...

Roche Diagnostics India, a part of the Roche Group, on Wednesday announced the appointment of Narendra Varde as Managing Director for India...

Everstone manages more than $5 billion worth of funds and had formed its healthcare platform Everlife in 2017.

Over the next 3-5 years, the company is mulling investment of over $100 million in India for these purposes, according to him.

Roche Diagnostics is part of Swiss healthcare major Roche. It sells devices and equipment to labs and hospitals and is mainly present in th...

The company has launched the new range of equipment under 'GEO' brand, Samsung India said in a statement.

Thyrocare plans to carry out complex experiments such as in vitro tests and to also launch company-owned outlets.

Manufacturers and importers of medical devices will soon have to face government's quality control norms as mandatory pre-requisite for per...